Familial interstitial disease with I73T mutation: A mid- And long-term study

Pediatric Pulmonology

Volumn 44, Issue 2, 2009, Pages 167-175

  Taam, Rola Abou ^a,b,c   Jaubert, Francis ^a,c   Emond, Sophie ^a,d   Bourgeois, Muriel Le ^a,b   Epaud, Ralph ^d   Karila, Chantal ^a,b   Feldmann, Delphine ^d   Scheinmann, Pierre ^a,b   De Blic, Jacques ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Centre de référence national maladies rares   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Child; Corticosteroids; Fibrosis; I73t mutation; Interstitial lung disease; Management; Pulmonary hypertension; SFTPC gene; Surfactant protein c

Indexed keywords

DNA; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; SURFACTANT PROTEIN C;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MEGADOSE; FAMILIAL DISEASE; FOLLOW UP; GENE MUTATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERSTITIAL LUNG DISEASE; LUNG BIOPSY; LUNG DISEASE; LUNG LAVAGE; OXYGEN THERAPY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; STEROID THERAPY; TREATMENT OUTCOME; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LUNG DISEASES, INTERSTITIAL; MALE; PEDIGREE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; TIME FACTORS;

EID: 59949094671     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20970     Document Type: Article

References (28)

1. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, Wert SE, Deutsch G, Nogee LM. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 2005;146:370-375.
2. Bullard JE, Nogee LM. Heterozygosity for ABCA3 mutations modifies the severity of lung disease associated with a surfactant protein C gene (SFTPC) mutation. Pediatr Res 2007;62:176-179.
3. Nogee LM, Dunbar AE, 3rd, Wert S, Askin F, Hamvas A, Whitsett JA. Mutations in the surfactant protein C gene associated with interstitial lung disease. Chest 2002;121:20S-21S.
4. Bullard JE, Wert SE, Whitsett JA, Dean M, Nogee LM. ABCA3 mutations associated with pediatric interstitial lung disease. Am J Respir Crit Care Med 2005;172:1026-1031. Epub 2005 Jun 23.
5. Somaschini M, Cavazza A, Riva S, Sassi I, carrera P. Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC. Pediatr Med Chir 2005;27:103-107.
6. Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-579.
7. Thomas AQ, Lane K, Phillips J, 3rd, Prince M, Markin C, Speer M, Schwartz DA, Gaddipati R, Marney A, Johnson J, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002;165:1322-1328.
8. Leibovitch L, Matok I, Paret G. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension. Drugs 2007;67:57-73.
9. Humpl T, Reyes JT, Holtby H, Stephens D, Adatia I. Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open- label, pilot study. Circulation 2005;111:3274-3280. Epub 2005 Jun 13.
10. Brasch F, Griese M, Tredano M, Johnen G, Ochs M, Rieger C, Mulugeta S, Muller KM, Bahuau M, Beers MF. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. Eur Respir J 2004;24:30-39.
11. Beers MF, Mulugeta S. Surfactant protein C biosynthesis and its emerging role in conformational lung disease. Annu Rev Physiol 2005;67:663-696.
12. Hartl D, Griese M. Interstitial lung disease in children genetic background and associated phenotypes. Respir Res 2005;6:32.
13. Hamvas A. Inherited surfactant protein-B deficiency and surfactant protein-C associated disease: clinical features and evaluation. Semin Perinatol 2006;30:316-326.
14. Amin RS, Wert SE, Baughman RP, Tomashefski JF, Jr., Nogee LM, Brody AS, Hull WM, Whitsett JA. Surfactant protein deficiency in familial interstitial lung disease. J Pediatr 2001;139:85-92.
15. Bridges JP, Xu Y, Na CL, Wong HR, Weaver TE. Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C. J Cell Biol 2006;172:395-407.
16. Nightingale JA, Rogers DF, Hart LA, Kharitonov SA, Chung KF, Barnes PJ. Effect of inhaled endotoxin on induced sputum in normal, atopic, and atopic asthmatic subjects. Thorax 1998;53:563-571.
17. Augusto LA, Synguelakis M, Espinassous Q, Lepoivre M, Johansson J, Chaby R. Cellular antiendotoxin activities of lung surfactant protein C in lipid vesicles. Am J Respir Crit Care Med 2003;168:335-341. Epub 2003 May 28.
18. Augusto LA, Synguelakis M, Johansson J, Pedron T, Girard R, Chaby R. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect Immun 2003;71:61-67.
19. Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem 2002;277:23484-23492. Epub 2002 Apr 29.
20. Augusto L, Le Blay K, Auger G, Blanot D, Chaby R. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol Lung Cell Mol Physiol 2001;281:L776-L785.
21. Deutsch GH, Young LR, Deterding RR, Fan LL, Del SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, et al. Diffuse lung disease in young children: application of a novel classification scheme. Am J Respir Crit Care Med 2007;176:1120-1128.
22. Percopo S, Cameron HS, Nogee LM, Pettinato G, Montella S, Santamaria F. Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation. Eur Respir J 2004; 24:1072-1073.
23. Desmarquest P, Tamalet A, Fauroux B, Boule M, Boccon-Gibod L, Tournier G, Glement A. Chronic interstitial lung disease in children: response to high-dose intravenous methylprednisolone pulses. Pediatr Pulmonol 1998;26:332-338.
24. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ. Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 2007;109:4313-4319. Epub 2007 Jan 25.
25. Kramer BW, Jobe AH, Ikegami M. Monocyte function in preterm, term, and adult sheep. Pediatr Res 2003;54:52-57.
26. Rosen DM, Waltz DA. Hydroxychloroquine and surfactant protein C deficiency. N Engl J Med 2005;352:207-208.
27. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-664.
28. Hamvas A, Nogee LM, White FV, Schuler P, Hackett BP, Huddleston CB, Mendeloff EN, Hsu FF, Wert SE, Gonzales LW, et al. Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene. Am J Respir Cell Mol Biol 2004;30:771-776. Epub 2003 Dec 4.